2022
DOI: 10.1016/j.molcel.2022.10.028
|View full text |Cite
|
Sign up to set email alerts
|

Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
29
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(29 citation statements)
references
References 82 publications
0
29
0
Order By: Relevance
“…Relying on these associated effectors, the long-B pAgos mediate Abi response to provide immunoprotection against invading plasmid. In particular, the long-B pAgo-nuclease system performs RNA-guided unspecific DNA degradation following recognition of a specific DNA target, indicating that both CRISPR-Cas systems and pAgo systems can utilize the target recognition-activated collateral DNA degradation as a defense strategy [30][31][32][33][34] .…”
Section: Introductionmentioning
confidence: 99%
“…Relying on these associated effectors, the long-B pAgos mediate Abi response to provide immunoprotection against invading plasmid. In particular, the long-B pAgo-nuclease system performs RNA-guided unspecific DNA degradation following recognition of a specific DNA target, indicating that both CRISPR-Cas systems and pAgo systems can utilize the target recognition-activated collateral DNA degradation as a defense strategy [30][31][32][33][34] .…”
Section: Introductionmentioning
confidence: 99%
“…Members of the superfamily are involved in restriction-modi cation systems, DNA metabolism, tRNA splicing 40 . Recently, many members of the superfamily are found as effectors of type III CRISPR-Cas and CBASS defense systems 30,31 . We expressed EcbAgaN in E. coli BL21 and puri ed it to apparent homogeneity (Figure S2A).…”
Section: Resultsmentioning
confidence: 99%
“…Genomic DNA degradation are performed by some defense systems as an immune strategy [29][30][31] , and potentially by more systems that employ nuclease effectors. In particular, a few type III CRISPR-Cas systems with NucC nucleases as effectors and type V-A2 CRISPR-Cas systems cleave genomic DNA after crRNA-directed target RNA recognition 29,30 .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations